April 22 (Reuters) - Abbott Laboratories reported a better-than-expected adjusted quarterly profit, driven by its branded generics, international nutrition and diagnostics divisions.
Sales in the company's division that sells branded generic drugs in emerging markets, jumped 31.8 percent in the first quarter even after including the impact of the strong dollar.
13:48 Wells Fargo Profit Falls 5.4% as Mortgage Revenue Declines24
12:08 Bank of America Profit Rises 43% on Trading Gains, Cost Cuts23
12:02 Bank of America tops earnings forecast, predicts 'significant increase' in net interest income20
10:27 India's Tata Consultancy third-quarter net up 10.9 percent, beats estimates20